Tech Company Financing Transactions
Novotech Funding Round
Novotech secured a funding round on 3/31/2025. Investors included GIC, Temasek and TPG Capital.
Transaction Overview
Company Name
Announced On
3/31/2025
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to accelerate its growth and pursue M&A opportunities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Level 19, 66 Goulburn Street
Sydney NSW, 2000
Australia
Sydney NSW, 2000
Australia
Phone
Website
Email Address
Overview
Novotech is a globally recognized full-service clinical research organization (CRO) and scientific advisory company that provides biotech and small- to mid-sized pharma companies an accelerated path to market since 1997. With a global footprint spanning 30+ offices across the Asia-Pacific region, North America, and Europe, and partnerships with 5,000+ trial sites, Novotech offers unparalleled access to key clinical trial destinations and diverse patient populations.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Moller
Chief Financial Officer
Rob Speedie
Chief Medical Officer
Judith Ng-Cashin
Chief Operating Officer
Michael Stibilj
VP - Bus. Development
Barry Murphy
VP - General Counsel
Veronica Holloway
VP - Human Resources
Angela Edwardson
Browse more venture capital transactions:
Prev: 3/31/2025: OpenAI venture capital transaction
Next: 3/31/2025: POCKLA venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs